Metformin inhibits the tumor-promoting effect of low-dose resveratrol, and enhances the anti-tumor activity of high-dose resveratrol by increasing its reducibility in triple negative breast cancer
Tingting Cheng, Cheng Wang, Qianqian Lu, Yuru Cao, Weiwei Yu, Wenzhen Li, Ben Liu, Xue Gao, Junhong Lü, Xiaohong Pan
Topics & Concepts
ResveratrolMetforminChemistryTriple-negative breast cancerPharmacologyApoptosisCatalaseCancer researchViability assayCell growthAntioxidantCancerMedicineBiochemistryBreast cancerInternal medicineInsulinSirtuins and Resveratrol in MedicineAdenosine and Purinergic SignalingMetabolism, Diabetes, and Cancer